![Cancers | Free Full-Text | Immunohistochemistry for Diagnosis of Metastatic Carcinomas of Unknown Primary Site Cancers | Free Full-Text | Immunohistochemistry for Diagnosis of Metastatic Carcinomas of Unknown Primary Site](https://pub.mdpi-res.com/cancers/cancers-10-00108/article_deploy/html/images/cancers-10-00108-g001.png?1569994562)
Cancers | Free Full-Text | Immunohistochemistry for Diagnosis of Metastatic Carcinomas of Unknown Primary Site
![A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases | Modern Pathology A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases | Modern Pathology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41379-019-0302-0/MediaObjects/41379_2019_302_Fig1_HTML.png)
A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases | Modern Pathology
![Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics](https://pubs.rsna.org/cms/10.1148/rg.2021210005/asset/images/medium/rg.2021210005.va.gif)
Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics
![Ovarian Dysgerminomas Pathology: Overview of Ovarian Dysgerminomas, Differentiating Ovarian Dysgerminomas, Laboratory Markers Ovarian Dysgerminomas Pathology: Overview of Ovarian Dysgerminomas, Differentiating Ovarian Dysgerminomas, Laboratory Markers](https://img.medscapestatic.com/pi/meds/ckb/00/12800tn.jpg)
Ovarian Dysgerminomas Pathology: Overview of Ovarian Dysgerminomas, Differentiating Ovarian Dysgerminomas, Laboratory Markers
Systematic validation and assessment of immunohistochemical markers for central nervous system pathology in cetaceans, with emphasis on auditory pathways | PLOS ONE
![Cureus | A Rare Presentation of Dual Ovarian Pathologies: Small Cell Carcinoma of the Ovary and Mucinous Ovarian Cancer Cureus | A Rare Presentation of Dual Ovarian Pathologies: Small Cell Carcinoma of the Ovary and Mucinous Ovarian Cancer](https://assets.cureus.com/uploads/figure/file/283089/lightbox_82675820408d11ec8f91a92ab50ba3e9-Img-1-edited-again.png)
Cureus | A Rare Presentation of Dual Ovarian Pathologies: Small Cell Carcinoma of the Ovary and Mucinous Ovarian Cancer
![A combination of immunohistochemical markers, MUC1, MUC5AC, PAX8 and growth pattern for characterization of mucinous neoplasm of the ovary | International Journal of Gynecologic Cancer A combination of immunohistochemical markers, MUC1, MUC5AC, PAX8 and growth pattern for characterization of mucinous neoplasm of the ovary | International Journal of Gynecologic Cancer](https://ijgc.bmj.com/content/ijgc/32/5/662/F1.large.jpg)
A combination of immunohistochemical markers, MUC1, MUC5AC, PAX8 and growth pattern for characterization of mucinous neoplasm of the ovary | International Journal of Gynecologic Cancer
![Role of immunohistochemistry in gynec oncopathology including specific diagnostic scenarios with associated treatment implications Rekhi B - Indian J Pathol Microbiol Role of immunohistochemistry in gynec oncopathology including specific diagnostic scenarios with associated treatment implications Rekhi B - Indian J Pathol Microbiol](https://www.ijpmonline.org/articles/2020/63/5/images/IndianJPatholMicrobiol_2020_63_5_70_279549_f2.jpg)
Role of immunohistochemistry in gynec oncopathology including specific diagnostic scenarios with associated treatment implications Rekhi B - Indian J Pathol Microbiol
![Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics](https://pubs.rsna.org/cms/10.1148/rg.2021210005/asset/images/medium/rg.2021210005.tbl1.png)
Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics
![Molecular Analysis of Clinically Defined Subsets of High-Grade Serous Ovarian Cancer - ScienceDirect Molecular Analysis of Clinically Defined Subsets of High-Grade Serous Ovarian Cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2211124720303922-fx1.jpg)
Molecular Analysis of Clinically Defined Subsets of High-Grade Serous Ovarian Cancer - ScienceDirect
![Frontiers | Tumor-Associated Macrophages in Human Breast, Colorectal, Lung, Ovarian and Prostate Cancers Frontiers | Tumor-Associated Macrophages in Human Breast, Colorectal, Lung, Ovarian and Prostate Cancers](https://www.frontiersin.org/files/Articles/566511/fonc-10-566511-HTML/image_m/fonc-10-566511-g001.jpg)
Frontiers | Tumor-Associated Macrophages in Human Breast, Colorectal, Lung, Ovarian and Prostate Cancers
![A1), (A2) and (A3) High immunohistochemical (IHC) staining of ROR1 in... | Download Scientific Diagram A1), (A2) and (A3) High immunohistochemical (IHC) staining of ROR1 in... | Download Scientific Diagram](https://www.researchgate.net/publication/264204559/figure/fig2/AS:203053509681168@1425423137615/A1-A2-and-A3-High-immunohistochemical-IHC-staining-of-ROR1-in-serous-papillary.png)